METHOD FOR CULTURING MAMMAL CELLS

DE602015092994T2Active Publication Date: 2026-02-11GENZYME CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE602015092994
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2014-12-22
Filing Date
2015-12-21
Publication Date
2026-02-11
Estimated Expiration
2035-12-21

AI Technical Summary

Technical Problem

Current methods for culturing mammalian cells to produce recombinant proteins are limited by the lack of flexibility and efficiency, particularly in achieving high cell densities and maintaining protein stability, especially with the use of poloxamer-188 concentrations above 5 g/L.

Method used

The method involves culturing mammalian cells with poloxamer-188 concentrations ranging from 1.8 g/L to 10.0 g/L, adjusting based on factors like pore size, pore type, gas flow rate, viable cell density, and cell stress markers, and using perfusion bioreactors to maintain optimal conditions for cell growth and protein production.

Benefits of technology

This approach enables high cell densities and improved protein production rates, achieving viable cell densities up to 200 x 10^6 cells/mL and maintaining protein stability, thus enhancing the efficiency and flexibility of recombinant protein manufacturing.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.